We are live on
!
Find out more
FAM
Fred Alger Management Portfolio holdings
AUM
$22.8B
1-Year Est. Return
64.63%
This Fund
S&P 500
This Quarter
Est. Return
+8.73%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$19.5B
AUM Growth
+$542M
(+2.9%)
Cap. Flow
-$738M
Cap. Flow
% of AUM
-3.79%
Top 10 Holdings %
Top 10 Hldgs %
40.49%
Holding
567
New
46
Increased
156
Reduced
216
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$148M |
| 2 |
Home Depot
HD
|
+$124M |
| 3 |
Philip Morris
PM
|
+$122M |
| 4 |
Microsoft
MSFT
|
+$119M |
| 5 |
Johnson Controls International
JCI
|
+$114M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$135M |
| 2 |
Verizon
VZ
|
+$107M |
| 3 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$92M |
| 4 |
Tesla
TSLA
|
+$85.9M |
| 5 |
Aptiv
APTV
|
+$84.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.16% |
| 2 | Healthcare | 19.18% |
| 3 | Communication Services | 17.29% |
| 4 | Consumer Discretionary | 12.02% |
| 5 | Industrials | 9.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Supernus Pharmaceuticals
SUPN
$2.68B
| $742K | ﹤0.01% |
30,000
+8,000
| +36% | +$181K |
|
327
American International
AIG
$41.9B
| $725K | ﹤0.01% |
12,213
+138
| +1% | +$7.88K |
|
328
AvalonBay Communities
AVB
$27.1B
| $719K | ﹤0.01% |
4,045
-6,410
| -61% | -$1.15M |
|
|
NVO
329
Novo Nordisk
NVO
$216B
| $707K | ﹤0.01% |
34,000
-1,700
| -5% | -$42.1K |
|
330
Itron
ITRI
$3.73B
| $700K | ﹤0.01% |
12,547
-448
| -3% | -$21.5K |
|
331
Bread Financial
BFH
$4.21B
| $699K | ﹤0.01% |
4,080
-12,173
| -75% | -$2.07M |
|
|
TTM
332
DELISTED
Tata Motors Limited
TTM
| $699K | ﹤0.01% |
17,480
+240
| +1% | +$9.31K |
|
333
Duke Energy
DUK
$102B
| $695K | ﹤0.01% |
8,687
+97
| +1% | +$8.03K |
|
334
Lincoln National
LNC
$7.91B
| $694K | ﹤0.01% |
14,780
| – | – |
|
335
Chipotle Mexican Grill
CMG
$40.8B
| $692K | ﹤0.01% |
81,750
-44,000
| -35% | -$362K |
|
336
Theravance Biopharma
TBPH
$874M
| $689K | ﹤0.01% |
19,000
+5,000
| +36% | +$139K |
|
|
CLVS
337
DELISTED
Clovis Oncology, Inc.
CLVS
| $685K | ﹤0.01% |
+19,000
| New | +$408K |
|
338
Woodward
WWD
$25B
| $683K | ﹤0.01% |
10,925
-5,820
| -35% | -$350K |
|
339
Wayfair
W
$11.1B
| $679K | ﹤0.01% |
+17,241
| New | +$697K |
|
|
HAR
340
DELISTED
Harman International Industries
HAR
| $669K | ﹤0.01% |
7,921
-434
| -5% | -$35.6K |
|
341
Adecoagro
AGRO
$1.53B
| $658K | ﹤0.01% |
57,703
+5,223
| +10% | +$55.2K |
|
342
Conagra Brands
CAG
$7.07B
| $650K | ﹤0.01% |
17,736
+3
| +0% | +$108 |
|
|
SPNC
343
DELISTED
Spectranetics Corp
SPNC
| $602K | ﹤0.01% |
24,000
+3,800
| +19% | +$88.6K |
|
344
West Pharmaceutical
WST
$23.1B
| $596K | ﹤0.01% |
8,000
-4,000
| -33% | -$318K |
|
345
AstraZeneca
AZN
$263B
| $591K | ﹤0.01% |
+9,000
| New | +$588K |
|
|
NBIS
346
Nebius Group N.V.
NBIS
$47.7B
| $575K | ﹤0.01% |
27,338
+8,055
| +42% | +$175K |
|
|
SCAI
347
DELISTED
Surgical Care Affiliates, Inc.
SCAI
| $561K | ﹤0.01% |
11,500
-2,000
| -15% | -$92.1K |
|
348
eBay
EBAY
$48.6B
| $560K | ﹤0.01% |
17,036
+257
| +2% | +$7.76K |
|
349
BorgWarner
BWA
$13.2B
| $553K | ﹤0.01% |
17,869
| – | – |
|
350
TG Therapeutics
TGTX
$8.58B
| $542K | ﹤0.01% |
70,000
+1,900
| +3% | +$12.2K |
|
Similar funds
CAM
BA
AM
SAM
CHP
Fred Alger Management's Q3 2016 Portfolio in Review
As of Q3 2016, Fred Alger Management held 567 positions worth $19.5B, up 2.9% from $18.9B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Fred Alger Management withdrew a net $738M in Q3 2016, closing 71 positions and reducing 216 holdings. Its most notable exit was TYCO INTL PLC COM SHS (IRL), an estimated $92M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Fred Alger Management opened a new position in Trip.com Group worth $55.6M.
- Fred Alger Management's largest Q3 2016 buy was Trip.com Group: 1,194,641 shares worth $55.6M.
- Fred Alger Management added most to Apple in Q3 2016, an estimated $148M increase.
- Fred Alger Management's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $135M.
- Fred Alger Management fully exited TYCO INTL PLC COM SHS (IRL) in Q3 2016, selling an estimated $92M.
- Fred Alger Management's ten largest holdings make up 40% of its $19.5B portfolio in Q3 2016.
- Fred Alger Management opened 46 new positions and closed 71 in Q3 2016.
- Fred Alger Management's portfolio value rose 2.9% quarter-over-quarter to $19.5B.
Based on Fred Alger Management's 13F filing for Q3 2016, filed 14 Nov 2016.